Glucagon-Like Peptide-1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Diabetes.

CONCLUSIONS: Adding exenatide to titrated glargine with metformin resulted in similar glycemic control as adding lispro and was well tolerated. These findings support exenatide as a noninsulin addition for patients failing basal insulin.
PMID: 25011946 [PubMed - as supplied by publisher]

Source: Diabetes Care - July 10, 2014 Category: Endocrinology Authors: Diamant M, Nauck MA, Shaginian R, Malone JK, Cleall S, Reaney M, de Vries D, Hoogwerf BJ, MacConell L, Wolffenbuttel BH, for the 4B Study Group Tags: Diabetes Care Source Type: research